To determine if Seprafilm® decreases the incidence of adhesion formation by 50% after primary cesarean. at repeat cesarean [clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b]

To determine if Seprafilm® decreases the incidence of adhesion formation by 50% after primary cesarean. at repeat cesarean [clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b]

Seprafilm®
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b
Seprafilm® for Prevention of Adhesions at Repeat Cesarean [clinicaltrials:NCT00697606]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

To determine if Seprafilm® decreases the incidence of adhesion formation by 50% after primary cesarean. at repeat cesarean [clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b]

Seprafilm®
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b
Bio2RDF identifier
88fc3e875609170c4fa4f1bef6970f3b
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b
measure [clinicaltrials_vocabulary:measure]
To determine if Seprafilm® dec ...... by 50% after primary cesarean.
time frame [clinicaltrials_vocabulary:time-frame]
description
identifier
clinicaltrials_resource:88fc3e875609170c4fa4f1bef6970f3b
title
To determine if Seprafilm® dec ...... y cesarean. at repeat cesarean
@en
inDataset
type
label
To determine if Seprafilm® dec ...... c3e875609170c4fa4f1bef6970f3b]
@en